Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer (vol 37, pg 2502, 2018)

被引：0
|
作者：
Sirkisoon, Sherona R. [1 ]
Carpenter, Richard L. [1 ]
Rimkus, Tadas [1 ]
Anderson, Ashley [1 ]
Harrison, Alexandria [1 ]
Lange, Allison M. [1 ]
Jin, Guangxu [2 ]
Watabe, Kounosuke [1 ,3 ]
Lo, Hui-Wen [1 ,3 ]
机构：
[1] Wake Forest Univ Sch Med, Dept Canc Biol, Winston Salem, NC 27104 USA
[2] Wake Forest Univ Sch Med, Dept Radiol, Winston Salem, NC USA
[3] Wake Forest Univ Sch Med, Wake Forest Comprehens Canc Ctr, Winston Salem, NC 27157 USA
来源：
ONCOGENE | 2024年 / 43卷 / 30期
关键词：
D O I：
10.1038/s41388-024-03084-3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：2371 / 2371
页数：1
相关论文
共 25 条
  • [21] Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein, Induces Phosphorylation of STAT3 and Apoptosis
    Spear, Jensen M.
    Lu, Zhixin
    Russu, Wade A.
    MOLECULES, 2020, 25 (23):
  • [22] Adipose stem cell exosomes, stimulated by pro-inflammatory factors, enhance immune evasion in triple-negative breast cancer by modulating the HDAC6/STAT3/PD-L1 pathway through the transporter UCHL1
    Zhu, Qin
    Zhang, Kejing
    Cao, Yukun
    Hu, Yu
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [23] αO-Conotoxin GeXIVA[1,2] Suppresses In Vivo Tumor Growth of Triple-Negative Breast Cancer by Inhibiting AKT-mTOR, STAT3 and NF-κB Signaling Mediated Proliferation and Inducing Apoptosis
    Guo, Xijun
    He, Leping
    Xu, Weifeng
    Wang, Wanrong
    Feng, Xiaoli
    Fu, Yuanfeng
    Zhang, Xiaofan
    Ding, Ren-Bo
    Qi, Xingzhu
    Bao, Jiaolin
    Luo, Sulan
    MARINE DRUGS, 2024, 22 (06)
  • [24] Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways
    Bai, Xue
    Ali, Amjad
    Lv, Zhimin
    Wang, Na
    Zhao, Xing
    Hao, Huifang
    Zhang, Yongmin
    Rahman, Faiz-Ur
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 224
  • [25] Efficacy + safety of palbociclib (P) in patients (pts) ≤50 y with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Subgroup analysis of 2 randomized phase 3 studies (vol 41s1, pg s11, 2018)
    Cristofanilli, Massimo
    Harbeck, Nadia
    Rugo, Hope S.
    Castrellon, Aurelio
    Joy, Anil Abraham
    Verma, Sunil
    Im, Seock-Ah
    Iyer, Shrividya
    Theall, Kathy Puyana
    Gauthier, Eric
    Huang, Xin
    Bartlett, Cynthia Huang
    Loibl, Sibylle
    Finn, Richard S.
    BREAST, 2020, 49 : 131 - 131
123